Literature DB >> 26311277

MicroRNAs as Therapeutic Targets in Colitis and Colitis-Associated Cancer: Tiny Players With a Giant Impact.

Ajay Goel1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26311277      PMCID： PMC4852471          DOI： 10.1053/j.gastro.2015.08.041

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  17 in total

1.  Inflammation and colorectal cancer: IBD-associated and sporadic cancer compared.

Authors:  Jonathan M Rhodes; Barry J Campbell
Journal:  Trends Mol Med       Date:  2002-01       Impact factor: 11.951

2.  Silencing of microRNAs in vivo with 'antagomirs'.

Authors:  Jan Krützfeldt; Nikolaus Rajewsky; Ravi Braich; Kallanthottathil G Rajeev; Thomas Tuschl; Muthiah Manoharan; Markus Stoffel
Journal:  Nature       Date:  2005-10-30       Impact factor: 49.962

3.  Survival and causes of death in Italian patients with ulcerative colitis. A GISC nationwide study.

Authors:  A Viscido; V Bagnardi; G C Sturniolo; V Annese; G Frieri; A D'Arienzo; C Papi; G Riegler; G Corrao; R Caprilli
Journal:  Dig Liver Dis       Date:  2001-11       Impact factor: 4.088

4.  Silencing of microRNA families by seed-targeting tiny LNAs.

Authors:  Susanna Obad; Camila O dos Santos; Andreas Petri; Markus Heidenblad; Oliver Broom; Cristian Ruse; Cexiong Fu; Morten Lindow; Jan Stenvang; Ellen Marie Straarup; Henrik Frydenlund Hansen; Troels Koch; Darryl Pappin; Gregory J Hannon; Sakari Kauppinen
Journal:  Nat Genet       Date:  2011-03-20       Impact factor: 38.330

5.  Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy.

Authors:  Yunching Chen; Xiaodong Zhu; Xiaoju Zhang; Bin Liu; Leaf Huang
Journal:  Mol Ther       Date:  2010-07-06       Impact factor: 11.454

6.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells.

Authors:  Hadi Valadi; Karin Ekström; Apostolos Bossios; Margareta Sjöstrand; James J Lee; Jan O Lötvall
Journal:  Nat Cell Biol       Date:  2007-05-07       Impact factor: 28.824

Review 7.  Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer.

Authors:  Linda A Feagins; Rhonda F Souza; Stuart J Spechler
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-05       Impact factor: 46.802

8.  MicroRNA-214 is aberrantly expressed in cervical cancers and inhibits the growth of HeLa cells.

Authors:  Zuozhen Yang; Shuang Chen; Xuejing Luan; Yixuan Li; Min Liu; Xin Li; Tao Liu; Hua Tang
Journal:  IUBMB Life       Date:  2009-11       Impact factor: 3.885

9.  MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha.

Authors:  Feng Wu; Michelle Zikusoka; Anil Trindade; Themistocles Dassopoulos; Mary L Harris; Theodore M Bayless; Steven R Brant; Shukti Chakravarti; John H Kwon
Journal:  Gastroenterology       Date:  2008-08-03       Impact factor: 22.682

10.  Post-transcriptional control of myc and p53 expression during differentiation of the embryonal carcinoma cell line F9.

Authors:  C Dony; M Kessel; P Gruss
Journal:  Nature       Date:  1985 Oct 17-23       Impact factor: 49.962
View more
  1 in total

Review 1.  Role of MiRNAs in Inflammatory Bowel Disease.

Authors:  Bo Cao; Xin Zhou; Jiaojiao Ma; Wei Zhou; Wanli Yang; Daiming Fan; Liu Hong
Journal:  Dig Dis Sci       Date:  2017-04-08       Impact factor: 3.199
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.